Joel Benjamin Heim
About
Joel Benjamin Heim is from Oslo, Oslo, Norway. Joel Benjamin works in the following industries: "Research Services". Joel Benjamin is currently Vaccine technology scientist at Nykode Therapeutics, located in Oslo, Oslo, Norway. In Joel Benjamin's previous role as a Oncology Scientist at Vaccibody AS, Joel Benjamin worked in Oslo, Norway until Oct 2021. Prior to joining Vaccibody AS, Joel Benjamin was a Postdoctoral Fellow at University of Oslo and held the position of Postdoctoral Fellow at Oslo Area, Norway. Prior to that, Joel Benjamin was a PhD Research Fellow at University of Oslo, based in Oslo und Umgebung, Norwegen from Aug 2015 to Mar 2019. Joel Benjamin started working as Dr. Smith H. and Lucille Gibson Research Fellowship at Mayo Clinic in Rochester und Umgebung, Minnesota in Oct 2014. From Mar 2014 to May 2014, Joel Benjamin was Erasmus-Master student at University of Oslo, based in Oslo und Umgebung, Norwegen. Prior to that, Joel Benjamin was a Internship at University of Tuebingen, based in Tübingen und Umgebung, Deutschland from Jan 2014 to Feb 2014. Joel Benjamin started working as Dr. Smith H. and Lucille Gibson Research Fellowship at Mayo Clinic in Rochester, Minnesota in Dec 2012.
If you’re looking for Joel Benjamin Heim's email address, you can find it on finalscout.com. Finalscout is a professional database with more than 500 million business professionals and 200 million company profiles.
Joel Benjamin Heim's current jobs
- Vaccine technology scientist - Early phase innovation - Vaccine discovery and design - Method development - Vaccine characterization - Innovation representative for the Vaccine Discovery department
Joel Benjamin Heim's past jobs
Postdoctoral Fellow at the Centre for Molecular Medicine (NCMM, Luecke group) Structural biology and drug discovery: Infectious diseases / Stomach cancer Methods: Plasmid design Bacterial cell culture Membrane protein purification Protein characterization (SDS-PAGE, Western blot, Thermal shift assay, GFP fluorescence assay, analytical SEC, negative stain EM) Structural biology
Protein Crystallography group of Prof. Ute Krengel Structural biology, Infectious diseases, Molecular biology, Biochemistry Pulling the “sweet tooth” of bacterial toxins – An investigation using X-ray crystallography and carbohydrate interaction analysis PhD defense: 25.03.2019 Methods: Plasmid design, PCR, Cloning Bacterial cell culture Soluble protein purification (cytosolic and periplasmic expression, IMAC, IEX, affinity chromatography, SEC) Cell culture assays (Teter lab and Fleckenstein lab) Protein characterization (SDS-PAGE, analytical SEC, ELISA, SPR, CD) Structural biology (X-ray crystallography, SAXS)
Dermatology, Alexander Meves M.D. Translational medicine, Molecular biology, Cell biology, Cancer research Master's thesis Methods: RNA extraction (cells, tissues, FFPE tissues), cDNA library, RT-PCR (Fluidigm assay) Mammalian cell culture Transfection, lentiviral transduction, Gene editing (Zink fingers) Mouse handling, Isolation of mouse embryos, Whole-mount 3d imaging Automated systems (epMotion, QIAcube, BOND-MAX, ProteinSimple, IncuCyte) Peptide pull down assay, GST-tagged proteins, Co-IP
Protein Crystallography group of Prof. Ute Krengel Protein biochemistry and crystallography Project: Purification, crystallization and X-ray analysis of the DAHP synthase of Corynebacterium glutamicum and Co-Crystallization experiments with chorismate mutase Methods: Molecular biology Protein purification (IMAC, SEC) Protein characterization (SDS-PAGE, analytical SEC) Structural biology (X-ray crystallography) Protein purification Protein crystallography, Co-crystallization experiments Antitumor antibodies
Structural biology group of Prof. Thilo Stehle Molecular biology, Protein purification, Protein crystallography Project: Crystallization and X-ray analysis of the DH* domain of corallopyronin A biosynthesis
Dermatology, Alexander Meves, M.D. Translational medicine, Molecular biology, Cell biology, Cancer research Project: The role of focal adhesion kinase in melanoma-induced extracellular matrix remodeling and identification of high-risk malignant melanoma by Fluidigm nanofluidic quantitative PCR. Methods: Reporter gene insertion by genome editing (zinc finger nucleases) facilitates screening for anti-melanoma chemical compounds RNA extraction (cells, tissues, FFPE tissues), cDNA library, RT-PCR (Fluidigm assay) Mammalian cell culture Gene knockdown (transfection, lentiviral transduction) Gene editing, reporter genes (Zinc finger nucleases, Luciferase) Mouse handling, Isolation of mouse embryos, Whole-mount 3d imaging Automated systems (epMotion, QIAcube, BOND-MAX)
Structural biology group of Prof. Thilo Stehle Structural biology, Molecular biology, Protein biochemistry Protein purification and characterization Protein crystallography X-Ray Diffraction Analysis (SLS, ESRF) Model building and structure analysis